Loricrin (LOR) Peptid
LOR
Reaktivität: Human
Wirt: Synthetic
BP, IHC, WB
-
- Target Alle LOR Produkte
- LOR (Loricrin (LOR))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-LOR antibody (Catalog #: ARP41738_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- LOR (Loricrin (LOR))
- Substanzklasse
- Chemical
- Hintergrund
-
LOR is a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in this gene are associated with Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases.LOR encodes loricrin, a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in LOR may be the cause of both Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases.
Alias Symbols: MGC111513
Protein Interaction Partner: EVPL,SPRR3,VIM,CSTA,IVL,KRT1,LOR,PI3,VIM
Protein Size: 316 - Molekulargewicht
- 35 kDa
- Gen-ID
- 4014
- NCBI Accession
- NM_000427, NP_000418
- UniProt
- P23490
-
Sie sind hier:
